Hoi-Kei Lon

Hoi-Kei Lon

AbbVie Inc - Chicago / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4633348
-
person_outline Hoi-Kei Lon's MOST POPULAR ARTICLES
1-) Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trialGU Höglinger, I Litvan, N Mendonca, D Wang, H Zheng, ...The Lancet Neurology 20 (3), 182-192, 2021762021
2-) Cytochrome P450 expression and regulation in CYP3A4/CYP2D6 double transgenic humanized miceMA Felmlee, HK Lon, FJ Gonzalez, AM YuDrug metabolism and disposition 36 (2), 435-441, 2008712008
3-) Pharmacokinetics, safety, and efficacy of glecaprevir/pibrentasvir in children with chronic HCV: part 2 of the DORA studyMM Jonas, S Rhee, DA Kelly, A Del Valle‐Segarra, C Feiterna‐Sperling, ...Hepatology 74 (1), 19-27, 2021412021
4-) Pharmacokinetic/pharmacodynamic modeling in inflammationHK Lon, D Liu, WJ JuskoCritical Reviews™ in Biomedical Engineering 40 (4), 2012442012
5-) Pharmacokinetic-pharmacodynamic disease progression model for effect of etanercept in Lewis rats with collagen-induced arthritisHK Lon, D Liu, Q Zhang, DC DuBois, RR Almon, WJ JuskoPharmaceutical research 28, 1622-1630, 2011422011